Details for 2014778739

Up to date per 05.04.2026

Actions

Title / Product Name

IMMUNHISTOCHEMISCHER TEST ZUM NACHWEIS DER EXPRESSION DES LIGANDEN 1 FÜR PROGRAMMIERTEN ZELLTOD (PD-L1) IN TUMORGEWEBE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2014778739

EP Publication Number

2981821

E-Number

1079265

Language

PCT Number

US14032305

Publication Date

10.02.2016 A

19.12.2018 B1

Registration Date

19.12.2018

AT Publication Date

15.01.2019

Application Date

31.03.2014

Registration Number

Priorities

02.04.2013

201361807581 P

IPC

G01N 33/53 20060101AFI20160919BHEP

Maximum Duration of Protection

31.03.2034

Owner

Merck Sharp & Dohme Corp.126 East Lincoln Avenue Rahway, NJ 07065-0907US

Representative

No representatives present

Inventor

DOLLED-FILHART, Marisa126 East Lincoln Avenue Rahway, New Jersey 07065-0907US

EMANCIPATOR, Kenneth126 East Lincoln Avenue Rahway, New Jersey 07065-0907US

LYNCH, Frank6483 Calle Real Suite A Goleta, California 93117US

PIERCE, Robert H.712 Bryant Street 5 San Francisco, California 94107US

WU, Dianna126 East Lincoln Avenue Rahway, New Jersey 07065-0907US